Steve Hoerter
2017
In 2017, Steve Hoerter earned a total compensation of $2.3M as Chief Commercial Officer at Agios Pharmaceuticals, a 44% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $205,177 |
|---|---|
| Option Awards | $1,639,353 |
| Salary | $427,451 |
| Other | $9,397 |
| Total | $2,281,378 |
Hoerter received $1.6M in option awards, accounting for 72% of the total pay in 2017.
Hoerter also received $205.2K in non-equity incentive plan, $427.5K in salary and $9.4K in other compensation.
Rankings
In 2017, Steve Hoerter's compensation ranked 4,867th out of 14,666 executives tracked by ExecPay. In other words, Hoerter earned more than 66.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,867 out of 14,666 | 67th |
Division Manufacturing | 1,736 out of 5,772 | 70th |
Major group Chemicals And Allied Products | 516 out of 2,075 | 75th |
Industry group Drugs | 399 out of 1,731 | 77th |
Industry Pharmaceutical Preparations | 318 out of 1,333 | 76th |
Source: SEC filing on April 18, 2018.
Hoerter's colleagues
We found four more compensation records of executives who worked with Steve Hoerter at Agios Pharmaceuticals in 2017.